Anaerobic pleuropulmonary infection

Current Opinion in Infectious Diseases

Volumn 14, Issue 2, 2001, Pages 187-191

  Levison, M E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOXITIN; CLINDAMYCIN; GATIFLOXACIN; GEMIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TELITHROMYCIN; TETRACYCLINE; TROVAFLOXACIN;

ACTINOMYCES; ANAEROBIC INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPIRATION PNEUMONIA; BACTERIUM CULTURE; BACTEROIDES; BLOOD CULTURE; FUSOBACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LIVER TOXICITY; LUNG INFECTION; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PHOTOTOXICITY; PORPHYROMONAS; PREVOTELLA; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA;

EID: 0035077401     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200104000-00013     Document Type: Article

References (29)

1. Treatment of anaerobic bacterial infections with clindamycin 2 phosphate
2. Bacteriologic flora of aspiration-induced pulmonary infections
3. Bacteriology of aspiration pneumonia, a prospective study of community and hospital acquired cases
4. Bacteriology of hospital-acquired pneumonia
5. The bacteriology of aspiration pneumonia
6. Treatment of aspiration pneumonia and primary lung abscess: Penicillin G vs. clindamycin
7. Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult to detect resistance mechanisms
8. Subgingival microflora and periodontitis
9. Bacteriology of anaerobic pleuropulmonary infection. Preliminary report
10. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy
11. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush
12. Is penicillin G adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures
13. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia, a prospective study
14. Anaerobic bacterial infections of the lung and pleural space
15. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess
16. Clindamycin vs. penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus
17. Clindamycin, metronidazole and chloramphenicol
18. Bacteroides, Prevotella and Porphyromonas species: A review of antibiotic resistance and therapeutic options
19. Metronidazole vs. clindamycin treatment of anaerobic Pulmonary infection: Failure of metronidazole therapy
20. Quinolone activity against anaerobes
21. In-vitro activities of gatifoxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria
22. Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens
23. Activities of gemifloxacin (SB 265805, LB 20304) compared to those of other oral antimicrobial agents against unusual anaerobes
24. Activity of gatifioxacin compared to five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections
25. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria
26. Practice guidelines for the management of community-acquired pneumonia in adults
27. Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the drug-resistant Streptococcus pneumoniae therapeutic working group
28. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes
29. Linezolid activity compared to those of other selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissues bite infections in humans